FDA Approves Cosentyx (secukinumab) for Moderate to Severe Hidradenitis Suppurativa in Adults and Pediatric Patients
The FDA approved a new use for the drug Cosentyx to treat a painful skin condition
The FDA has approved Cosentyx for moderate to severe hidradenitis suppurativa in adults and pediatric patients 12 years and older.
The FDA has approved Cosentyx for treating moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps.
Review suggests automated stool management system may reduce costs and nursing time in ICU fecal incontinence
New Device Cuts ICU Fecal Incontinence Costs By 90%
This narrative review synthesizes evidence on the Qoramatic Automated Stool Management system versus traditional methods for fecal incontine…
A new automated device could save hospitals thousands of dollars while keeping patients cleaner and safer.
Review of cohort data finds AD linked to psoriasis risk and biologics associated with lower risk
Atopic Dermatitis Raises Psoriasis Risk, But Biologics Help
This narrative review synthesizes findings from a large cohort study.
A massive study shows that while eczema increases the chance of getting psoriasis, modern biologic drugs significantly protect against this …
FDA Approves Stelara (ustekinumab) for moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis
The FDA approved a drug called Stelara to treat several inflammatory conditions in adults and children
The FDA approved ustekinumab for adult and pediatric patients 6 years and older with moderate to severe plaque psoriasis and active psoriati…
FDA approved Stelara to treat moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis in adults an…
FDA Approves Stelara (ustekinumab) for moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis
The FDA has approved a new drug called Stelara for several inflammatory conditions
The FDA approved ustekinumab for adult and pediatric patients 6 years and older with moderate to severe plaque psoriasis and active psoriati…
The FDA has approved Stelara to treat moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis in a…
Review of chronic skin ulcers in Burkina Faso highlights Buruli ulcer prevalence in pediatric patients
The Skin Wound That Shame Keeps Hidden — and Why That's Dangerous
This cross-sectional review analyzes data from 104 patients with chronic skin ulcers seen at two university hospitals in Burkina Faso.
Shame keeps chronic skin wounds hidden in Burkina Faso, where stigma delays care and lets a flesh-destroying bacterial infection spread amon…
FDA Approves Abreva () for cold sores/fever blisters on the face or lips to shorten healing time and duration of symptoms
The FDA has approved a new non-prescription drug called Abreva for treating cold sores
The FDA approved Abreva for treating cold sores/fever blisters on the face or lips to shorten healing time and duration of symptoms such as …
FDA approves new over-the-counter drug Abreva to shorten cold sore healing time and ease painful symptoms like tingling and itching.
Guselkumab Phase III trials validate 3VAS and 4VAS measures for psoriatic arthritis disease activity assessment
Study checks how well pain scores track joint damage in psoriatic arthritis patients
Phase III randomized clinical trials in 1,405 participants with psoriatic arthritis evaluated guselkumab treatment through week 100.
Pain scores for psoriatic arthritis strongly predict long-term joint damage, giving doctors clear numbers to track real progress and adjust …
Systematic review of public health interventions to curb respiratory infections at sporting mass gatherings
How Sports Events Can Stop Virus Spread
This systematic review synthesized 34 articles covering 37 sporting mass gatherings, most commonly the Olympic Games, to map public health i…
Smart planning at big sports events can safely protect fans and athletes from catching respiratory infections.
Machine learning and deep learning applications in inguinal hernia care show promise for risk prediction and training
AI Is Changing How Doctors Diagnose and Repair Hernias
This narrative review evaluates machine learning (ML) and deep learning (DL) applications in inguinal hernia management.
Artificial intelligence now helps surgeons predict hernia surgery risks and navigate anatomy in real time to improve patient outcomes.
Atopic constitution associated with severe Mycoplasma pneumoniae pneumonia in children
Why Allergy-Prone Kids Get Sicker From This Common Lung Infection
This retrospective cohort study examined 377 children with Mycoplasma pneumoniae pneumonia at Wuhan Children's Hospital.
Allergy-prone children face a higher risk of severe pneumonia from Mycoplasma, and two simple blood tests could flag who needs closer watchi…
Occupational noise exposure linked to cognitive decline in cross-sectional study of 170 workers
Loud Job Sites May Be Costing Workers More Than Hearing
A cross-sectional study of 170 noise-exposed workers found hearing loss was significantly associated with cognitive decline.
Hearing protection on a noisy worksite may shield not only your ears but also how sharply your brain works in the years ahead.